Immunotherapy trials for Lung cancer

All Immunotherapy trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Immunotherapy for Lung cancer

• A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
  NCT07293247 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 74 locations
• AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer
  NCT06788366 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Association of Psychological Distress in Patients With Lung Cancer
  NCT06218901 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
  NCT06410300 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC
  NCT06718309 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer
  NCT06719700 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer
  NCT07034326 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC
  NCT06810609 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · 5 locations
• PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
  NCT06102057 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
  NCT04151940 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)
  NCT06943235 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China
  NCT04286841 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Immunotherapy for Lung cancer?

12 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.